The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab

This publication has 44 references indexed in Scilit:

• Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  Annals of Oncology, 2024
• The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study
  Irish Journal of Medical Science (1971 -), 2019
• Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma
  Medical Oncology, 2016
• The role of HIF1α in renal cell carcinoma tumorigenesis
  Journal of Molecular Medicine, 2014
• The sex difference in haemoglobin levels in adults — Mechanisms, causes, and consequences
  Blood Reviews, 2014
• The emerging role of nuclear factor kappa B in renal cell carcinoma
  The International Journal of Biochemistry & Cell Biology, 2011
• Determinants of Red Cell Distribution Width (RDW) in Cardiorenal Patients: RDW is Not Related to Erythropoietin Resistance
  Journal of Cardiac Failure, 2011
• VHL and HIF signalling in renal cell carcinogenesis
  The Journal of Pathology, 2010
• Sunitinib‐induced macrocytosis in patients with metastatic renal cell carcinoma
  Cancer, 2008
• Anemia as an independent prognostic factor for survival in patients with cancer
  Cancer, 2001